BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
ID: 352511Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a Notice of Funding Opportunity (NOFO) aimed at developing production and distribution facilities for brain cell type-specific access reagents as part of the BRAIN Initiative. This initiative seeks to enhance neurotechnologies that improve the understanding of brain function and the development of treatments for brain disorders, with a focus on scaling up the production of specific reagents such as viral vectors and nucleic acid constructs. Successful applicants will be required to collaborate with Research Resource for Design and Development (RRDD) projects, execute scaled production, and ensure broad dissemination of these reagents while promoting diversity within research teams through a Plan for Enhancing Diverse Perspectives (PEDP). The anticipated funding is approximately $2.4 million per year to support 2 to 4 awards, with a maximum project period of 5 years. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with applications due by July 1, 2026.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is issuing a Notice of Funding Opportunity (NOFO) aimed at developing production and distribution facilities for brain cell type-specific access reagents as part of the BRAIN Initiative. The initiative focuses on advancing neurotechnologies to enhance understanding of brain function and the development of treatments for brain disorders. The funding opportunity (RFA-MH-25-105) seeks applications to scale up the production of specific reagents—like viral vectors and nucleic acid constructs—that facilitate detailed studies of neural circuits. Successful applicants must interface with Research Resource for Design and Development (RRDD) projects, execute scaled production, disseminate reagents broadly, and coordinate data management. An emphasis is placed on diversity and inclusivity within research teams; applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposal. The anticipated funding is estimated at $2.4 million per year to support 2 to 4 awards, with an application maximum project period of 5 years. The NOFO aims to foster collaboration across institutions and disciplines to enrich neuroscience research through the broad availability of these specialized reagents.
    Similar Opportunities
    BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the BRAIN Initiative aimed at scaling up brain cell type-specific molecular or genetic access reagents across vertebrate species. This initiative seeks to develop and validate viral, non-viral, transgenic, and gene regulatory element screening technologies to enhance neuroscience research and improve understanding of brain circuits, ultimately aiding in the treatment of brain disorders. The program anticipates a total funding of $14 million per year, with a maximum project period of five years, and encourages applications from a diverse range of eligible institutions, including historically black colleges, tribal colleges, and non-profit organizations. Interested applicants should submit their proposals by January 17, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience," aimed at supporting the establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions. The objective is to facilitate the scaled production and distribution of brain cell type-specific access and manipulation reagents, which are crucial for advancing neuroscience research by enabling precise probing of circuit functions in experimental animals and human tissues. This initiative is part of the BRAIN Initiative Armamentarium project, and awardees will collaborate with other researchers to manufacture and distribute various reagents, including viral vectors and nucleic acid constructs. Interested applicants can find more information and apply before the closing date of June 15, 2027, by visiting the NIH grants website or contacting NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Notice of Funding Opportunity (NOFO) for the BRAIN Initiative, aimed at developing web-accessible data archives to capture, store, and curate data related to neuroscience research. The initiative seeks to enhance research efforts by establishing community resource data archives that adhere to high-quality data standards and improve accessibility for the research community. With an anticipated funding amount of $4 million, NIH plans to award 3-4 grants, each lasting up to five years, and applicants are required to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with applications due by June 24, 2026.
    BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System," aimed at advancing neuroscience research through innovative technology development. This initiative seeks applications for the creation of new hardware, software, or molecular constructs that address challenges in recording and modulating neural cells and circuits, with a focus on high-risk projects that could lead to transformative outcomes in understanding dynamic signaling within the central nervous system. The program allocates an estimated $10 million annually for 15-20 awards, emphasizing collaboration across scientific domains and encouraging participation from diverse institutions, particularly those supporting early-career researchers and underserved populations. Interested applicants should note that the application submission deadlines begin on May 2, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the BRAIN Initiative, aimed at developing and validating novel tools to analyze cell-specific and circuit-specific processes in the brain. This initiative seeks proposals that focus on creating innovative technologies to enhance the understanding of complex neural behaviors and interactions, particularly tools that are non-invasive and applicable across various model organisms. The program is critical for advancing research in brain function and disorders, with an estimated funding total of $8 million to support 6-9 awards, and applications are due by May 7, 2024. Interested applicants must submit a Plan for Enhancing Diverse Perspectives (PEDP) and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative, titled "New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)." This initiative aims to support proof-of-concept testing and the development of innovative neurotechnologies that can enhance the understanding of brain circuit dynamics and facilitate transformative neuroscience research. The program encourages high-risk, high-impact projects that integrate diverse scientific domains and require applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. The total estimated funding available is $10 million annually, with plans to support 15-20 awards over a maximum project period of three years. Interested applicants must adhere to strict submission guidelines, and the application deadline is January 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the BRAIN Initiative, specifically targeting the development of next-generation sensor technology to enhance the understanding of brain behavior. This initiative aims to solicit applications for research focused on the creation and preclinical testing of innovative sensors and bioelectronics as part of the Brain Behavior Quantification and Synchronization Program. The anticipated NOFO is expected to be published in Fall 2024, with applications due in late Spring 2025, and the estimated award date is set for April 1, 2026. Interested applicants should prepare to collaborate and develop responsive projects, as there are no cost-sharing requirements associated with this cooperative agreement.
    BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System," aimed at enhancing technologies for recording neural activity and addressing significant challenges in neuroscience research. This initiative seeks applications focused on optimizing existing or emerging technologies through iterative testing with end users, with the goal of improving network recording capabilities and developing tools for circuit manipulation that can be validated in vivo. The funding, anticipated at $10 million per year for 15-20 awards, requires applicants to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research, with submissions due by January 20, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for research on the ethical implications of advancements in neurotechnology and brain science, designated as R21 Clinical Trial Optional grants. This initiative invites multi-disciplinary teams to explore critical ethical issues related to brain research, including topics such as brain imaging, data privacy, and informed consent, with the aim of fostering diverse collaborations and addressing significant ethical challenges in the field. The total funding available is $2 million annually over three years, supporting up to eight new awards, with individual project budgets capped at $275,000 for a two-year period. Interested applicants should note that the application period opens on September 11, 2024, and closes on October 9, 2026; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.